Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients
The secondary analysis from VOYAGER PAD adds reassurance on top of similar data from COMPASS, says Geoffrey Barnes.
Source: tctmd.com
📰 Benefit Across News
Benefit Across News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Benefit Across. Real-time updates on events, politics, business and more.